Displaying 217 - 228 of 492
Immune-Mediated and Cholestatic Diseases

Potential for IBAT Inhitors in PSC: Will the Paediatric Experience Translate to Adults?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Q&A and Close

Webcasts
View
Metabolism, Alcohol & Toxicity

Summary and closing remarks

Webcasts
View
Metabolism, Alcohol & Toxicity

Welcome and Introduction

Webcasts
View
Metabolism, Alcohol & Toxicity

Sanofi: Reducing the burden of liver disease - new evidence revealed (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

MAFLD in Focus: Unveiling Insights from RELIEF Study - Insight from APASL 2024

Webcasts
View
Metabolism, Alcohol & Toxicity

Metabolic and toxic liver damage in focus - MANPOWER's Latest Breakthroughs Revealed.

Webcasts
View
Metabolism, Alcohol & Toxicity

Shedding light on genomic, metabolic, and phenotypic effects of essential phospholipids on HepaRG

Webcasts
View
Metabolism, Alcohol & Toxicity

Metabolic Comorbidities Unmasked -  Redefining MASLD/MASH Impact

Webcasts
View
Metabolism, Alcohol & Toxicity

Q&A

Webcasts
View
General Hepatology

Welcome and Introduction

Webcasts
View
General Hepatology

Boehringer Ingelheim: Champions for the liver in an interconnected era – how can hepatologists reshape clinical practice to be...

Webcasts
View
Displaying 217 - 228 of 492